GH Research PLC (GHRS) Comparison with companies in other sectors?

GH Research PLC has a share price of 62.03M. You can analyze GH Research PLC (GHRS) competitors across different market sectors through stock heatmaps.

What are GHRS's NET and operating margins?

GH Research PLC (GHRS) operating margin is around 0.00, and net profit margin is approximately 0.00 as of the latest reports.

In what way does GHRS's earnings per share (EPS) trend reflect its financial momentum?

GH Research PLC (GHRS) EPS is -0.79 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for GH Research PLC is -18.27, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for GH Research PLC?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for GH Research PLC like P/E which is -19.94, P/B which is 2.71, and PEG which is 3.74. Compare them with sector averages to evaluate if the stock is priced fairly.

GH Research PLC

GHRS•NASDAQ

Healthcare

Biotechnology

$14.50

$0.010(0.07%)

Fundamental Analysis of GH Research PLC (GHRS)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$-0.79

P/E Ratio

-18.27

ROE

-0.19%

Net Margin

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$895.07M

Shares OutstandingTotal number of shares issued

$62.03M

Book Value/ShareNet worth per share

$5.35

Revenue/ShareAnnual revenue per share

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$-0.79

Net MarginNet income as percentage of revenue

Operating MarginOperating income as percentage of revenue

ROEReturn on shareholders' equity

-19.20%

ROAReturn on total assets

-13.14%

ROCEReturn on capital employed

-16.59%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$-0.71

Cash/ShareCash and equivalents per share

$5.02

FCF YieldFree cash flow as percentage of market cap

-4.58%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for GHRSFinancial Ratios Analysis details for GHRS are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for GHRSSector Benchmarking details for GHRS are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for GH Research PLC Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of GH Research PLC. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account GH Research PLC's unique business strengths and challenges.

Key Financial Metrics for GH Research PLC

For GH Research PLC, essential financial indicators include EPS -0.79, PE -18.27, and ROE -0.19. These key ratios reveal insights into GH Research PLC's profitability, valuation, and operational health. Understanding these metrics enables you to compare GH Research PLC with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of GH Research PLC

Metrics like Net Margin - and ROA -13.14% shed light on how well GH Research PLC is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether GH Research PLC can sustain its operations and continue growing in the future.

Valuation and Market Position of GH Research PLC

Using ratios such as P/B Ratio 2.71 and PEG Ratio 3.74, investors can assess whether GH Research PLC is appropriately valued based on its financials and growth potential. These figures, combined with GH Research PLC's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for GH Research PLC

Financial health indicators, such as Debt/Equity Ratio 0.002 and Cash Flow $-0.71, provide a snapshot of GH Research PLC's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like GH Research PLC, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for GH Research PLC

Investing in GH Research PLC based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at GH Research PLC focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;